MHRA approves Rozanolixizumab for myasthenia gravis patients Science March 7, 2024 United Kingdom: The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the medicine Rozanolixizumab (Rystiggo) to treat adults with generalised…